Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
Mayo Clinic
Mayo Clinic
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center